Wendy Stock to Hodgkin Disease
This is a "connection" page, showing publications Wendy Stock has written about Hodgkin Disease.
Connection Strength
0.313
-
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
Score: 0.183
-
Impact of treatment site on disparities in outcome among adolescent and young adults with Hodgkin lymphoma. Leukemia. 2017 06; 31(6):1450-1453.
Score: 0.120
-
Progressive transformation of germinal centers. Report of 2 cases and review of the literature. Acta Haematol. 2002; 108(1):33-8.
Score: 0.010